Phenotypic characterization of the lymphocyte compartment and somatic hypermutations in ICOS deficiency
. | Age at testing, y . | Lymphocyte count, × 109/L . | CD3, %Ly . | CD4, %Ly . | CD8, %Ly . | CD19, %Ly . | CD19/μL . | CD27-IgD+, %Bc . | CD27+IgD+, %Bc . | CD27+IgD-, %Bc . | SHM, %bp . |
---|---|---|---|---|---|---|---|---|---|---|---|
Family A | |||||||||||
Patient 1 | 41 | 1.266 | 95.6* | 59.2* | 31.9 | 0.6* | 7* | 89.6* | 5.9* | 0.8* | ND |
Patient 2 | 32 | 1.047 | 88.5* | 39.9 | 47.2* | 0.6* | 9* | 88.5* | 7.8* | 1.6* | 3.8 |
Family B | |||||||||||
Patient 3 | 35 | 1.171 | 77.6 | 50.5 | 22.8 | 2.8* | 34* | 94.9* | 4.1* | 0.2* | —† |
Patient 4 | 25 | 0.353* | 91.9* | 44.8 | 33.6 | 3.2* | 5* | 92.9* | 5.1* | 0.3* | ND |
Family C | |||||||||||
Patient 5 | 46 | 0.871* | 72.2 | 55.1 | 16.6 | 14.6 | 127 | 90.4* | 9 | 0.2* | 2.2* |
Patient 6 | 42 | 1.722 | 91.9* | 23.1 | 64.0* | 2.01* | 33* | 90.2* | 11.3 | 1.3* | ND |
Family D | |||||||||||
Patient 7 | 18 | 3.031 | 88.5* | 40.8 | 47.5* | 6.1 | 184 | 96.8* | 2.7* | 0* | —† |
Patient 8 | 5 | 3.584 | 76.1 | 39.0 | 34.5 | 19.1 | 686 | 95.2* | 3.2* | 1.3* | 2.3* |
Patient 9 | 5 | 4.153 | 70.4 | 32.8 | 34.8 | 21.2 | 882 | 97.7* | 2* | 0* | —† |
Mean ± SD | — | 1.910 ± 1.262 | 83.6 ± 9.0 | 42.8 ± 10.5 | 37.0 ± 13.4 | 7.8 ± 7.7 | 219 ± 311 | 92.9 ± 3.2 | 5.7 ± 3.0 | 0.6 ± 0.6 | 2.8 ± 0.7 |
Normal range | — | 1.0-2.8 | 55-83 | 28-57 | 10-39 | 6-19 | 100-500 | 38-80 | 7.9-36 | 6.5-33 | 2.5-6.3 |
. | Age at testing, y . | Lymphocyte count, × 109/L . | CD3, %Ly . | CD4, %Ly . | CD8, %Ly . | CD19, %Ly . | CD19/μL . | CD27-IgD+, %Bc . | CD27+IgD+, %Bc . | CD27+IgD-, %Bc . | SHM, %bp . |
---|---|---|---|---|---|---|---|---|---|---|---|
Family A | |||||||||||
Patient 1 | 41 | 1.266 | 95.6* | 59.2* | 31.9 | 0.6* | 7* | 89.6* | 5.9* | 0.8* | ND |
Patient 2 | 32 | 1.047 | 88.5* | 39.9 | 47.2* | 0.6* | 9* | 88.5* | 7.8* | 1.6* | 3.8 |
Family B | |||||||||||
Patient 3 | 35 | 1.171 | 77.6 | 50.5 | 22.8 | 2.8* | 34* | 94.9* | 4.1* | 0.2* | —† |
Patient 4 | 25 | 0.353* | 91.9* | 44.8 | 33.6 | 3.2* | 5* | 92.9* | 5.1* | 0.3* | ND |
Family C | |||||||||||
Patient 5 | 46 | 0.871* | 72.2 | 55.1 | 16.6 | 14.6 | 127 | 90.4* | 9 | 0.2* | 2.2* |
Patient 6 | 42 | 1.722 | 91.9* | 23.1 | 64.0* | 2.01* | 33* | 90.2* | 11.3 | 1.3* | ND |
Family D | |||||||||||
Patient 7 | 18 | 3.031 | 88.5* | 40.8 | 47.5* | 6.1 | 184 | 96.8* | 2.7* | 0* | —† |
Patient 8 | 5 | 3.584 | 76.1 | 39.0 | 34.5 | 19.1 | 686 | 95.2* | 3.2* | 1.3* | 2.3* |
Patient 9 | 5 | 4.153 | 70.4 | 32.8 | 34.8 | 21.2 | 882 | 97.7* | 2* | 0* | —† |
Mean ± SD | — | 1.910 ± 1.262 | 83.6 ± 9.0 | 42.8 ± 10.5 | 37.0 ± 13.4 | 7.8 ± 7.7 | 219 ± 311 | 92.9 ± 3.2 | 5.7 ± 3.0 | 0.6 ± 0.6 | 2.8 ± 0.7 |
Normal range | — | 1.0-2.8 | 55-83 | 28-57 | 10-39 | 6-19 | 100-500 | 38-80 | 7.9-36 | 6.5-33 | 2.5-6.3 |
Lymphocyte subpopulations were analyzed by flow cytometry with the following markers: CD3 for total T cells and CD4 and CD8 for the respective subpopulations, CD19 for B cells with naive (CD27-IgD+), IgM memory (CD27+IgD+), and switched memory (CD27+IgD-) subpopulations. Normal ranges are determined for adult population.
%Ly indicates percentage of lymphocytes; %Bc, percentage of B cells; SHM, somatic hypermutation; %bp, percentage of mutated base pairs; ND, not determined; —, not applicable.
Pathologic values.
The percentage of CD19+CD27+ cells was too low for analysis.